Literature DB >> 16622520

Analysis of expressed and non-expressed IGK locus rearrangements in chronic lymphocytic leukemia.

Chrysoula Belessi1, Kostas Stamatopoulos, Anastasia Hadzidimitriou, Katerina Hatzi, Tatjana Smilevska, Niki Stavroyianni, Fotini Marantidou, George Paterakis, Athanasios Fassas, Achilles Anagnostopoulos, Nikolaos Laoutaris.   

Abstract

Immunoglobulin kappa (IGK) locus rearrangements were analyzed in parallel on cDNA/genomic DNA in 188 kappa- and 103 lambda-chronic lymphocytic leukemia (CLL) cases. IGKV-KDE and IGKJ-C-intron-KDE rearrangements were also analyzed on genomic DNA. In kappa-CLL, only 3 of 188 cases carried double in-frame IGKV-J transcripts: in such cases, the possibility that leukemic cells expressed more than one kappa chain cannot be excluded. Twenty-eight kappa-CLL cases also carried nonexpressed (nontranscribed and/or out-of-frame) IGKV-J rearrangements. Taking IGKV-J, IGKV-KDE, and IGKJ-C-intron-KDE rearrangements together, 38% of kappa-CLL cases carried biallelic IGK locus rearrangements. In lambda-CLL, 69 IGKV-J rearrangements were detected in 64 of 103 cases (62%); 24 rearrangements (38.2%) were in-frame. Four cases carried in-frame IGKV-J transcripts but retained monotypic light-chain expression, suggesting posttranscriptional regulation of allelic exclusion. In all, taking IGKV-J, IGKV-KDE, and IGKJ-C-intron-KDE rearrangements together, 97% of lambda-CLL cases had at least 1 rearranged IGK allele, in keeping with normal cells. IG repertoire comparisons in kappa- versus lambda-CLL revealed that CLL precursor cells tried many rearrangements on the same IGK allele before they became lambda producers. Thirteen of 28 and 26 of 69 non-expressed sequences in, respectively, kappa- or lambda-CLL had < 100% homology to germline. This finding might be considered as evidence for secondary rearrangements occurring after the onset of somatic hypermutation, at least in some cases. The inactivation of potentially functional IGKV-J joints by secondary rearrangements indicates active receptor editing in CLL and provides further evidence for the role of antigen in CLL immunopathogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16622520      PMCID: PMC1449522          DOI: 10.2119/2005-00044.Belessi

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  77 in total

1.  Molecular cross-talk between the transcription, translation, and nonsense-mediated decay machineries.

Authors:  Francisco J Iborra; Alexandre E Escargueil; Kon Y Kwek; Alexandre Akoulitchev; Peter R Cook
Journal:  J Cell Sci       Date:  2004-02-03       Impact factor: 5.285

2.  IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis.

Authors:  Véronique Giudicelli; Denys Chaume; Marie-Paule Lefranc
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

3.  Efficient downregulation of immunoglobulin mu mRNA with premature translation-termination codons requires the 5'-half of the VDJ exon.

Authors:  Marc Bühler; Alexandra Paillusson; Oliver Mühlemann
Journal:  Nucleic Acids Res       Date:  2004-06-21       Impact factor: 16.971

4.  Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia.

Authors:  Fabio Ghiotto; Franco Fais; Angelo Valetto; Emilia Albesiano; Shiori Hashimoto; Mariella Dono; Hideyuki Ikematsu; Steven L Allen; Jonathan Kolitz; Kanti R Rai; Marco Nardini; Anna Tramontano; Manlio Ferrarini; Nicholas Chiorazzi
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

5.  Non-functional immunoglobulin G transcripts in a case of hyper-immunoglobulin M syndrome similar to type 4.

Authors:  John M Darlow; Alex M Farrell; David I Stott
Journal:  Immunology       Date:  2004-02       Impact factor: 7.397

6.  Molecular mechanisms and selective influences that shape the kappa gene repertoire of IgM+ B cells.

Authors:  S J Foster; H P Brezinschek; R I Brezinschek; P E Lipsky
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

7.  Characterization of a germline Vk gene encoding cationic anti-DNA antibody and role of receptor editing for development of the autoantibody in patients with systemic lupus erythematosus.

Authors:  N Suzuki; T Harada; S Mihara; T Sakane
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

8.  Editing disease-associated autoantibodies.

Authors:  C Chen; E L Prak; M Weigert
Journal:  Immunity       Date:  1997-01       Impact factor: 31.745

Review 9.  The molecular basis and biological significance of VH replacement.

Authors:  Zhixin Zhang; Peter D Burrows; Max D Cooper
Journal:  Immunol Rev       Date:  2004-02       Impact factor: 12.988

10.  Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia.

Authors:  Bradley T Messmer; Emilia Albesiano; Dimitar G Efremov; Fabio Ghiotto; Steven L Allen; Jonathan Kolitz; Robin Foa; Rajendra N Damle; Franco Fais; Davorka Messmer; Kanti R Rai; Manlio Ferrarini; Nicholas Chiorazzi
Journal:  J Exp Med       Date:  2004-08-16       Impact factor: 14.307

View more
  4 in total

1.  Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection.

Authors:  Emanuela M Ghia; Sonia Jain; George F Widhopf; Laura Z Rassenti; Michael J Keating; William G Wierda; John G Gribben; Jennifer R Brown; Kanti R Rai; John C Byrd; Neil E Kay; Andrew W Greaves; Thomas J Kipps
Journal:  Blood       Date:  2008-03-07       Impact factor: 22.113

2.  Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference.

Authors:  Panagiotis Baliakas; Anna Puiggros; Aliki Xochelli; Lesley-Ann Sutton; Florence Nguyen-Khac; Anne Gardiner; Karla Plevova; Eva Minga; Anastasia Hadzidimitriou; Renata Walewska; Helen McCarthy; Margarita Ortega; Rosa Collado; Teresa González; Isabel Granada; Elisa Luño; Jana Kotašková; Theodoros Moysiadis; Zadie Davis; Niki Stavroyianni; Achilles Anagnostopoulos; Jonathan C Strefford; Sarka Pospisilova; Frederic Davi; Anastasia Athanasiadou; Richard Rosenquist; David Oscier; Blanca Espinet; Kostas Stamatopoulos
Journal:  Haematologica       Date:  2016-04-21       Impact factor: 9.941

3.  Partial versus productive immunoglobulin heavy locus rearrangements in chronic lymphocytic leukemia: implications for B-cell receptor stereotypy.

Authors:  Eugenia Tsakou; Andreas Agathangelidis; Andreas Agathagelidis; Myriam Boudjoghra; Thorsten Raff; Antonis Dagklis; Maria Chatzouli; Tatjana Smilevska; George Bourikas; Helene Merle-Beral; Eleni Manioudaki-Kavallieratou; Achilles Anagnostopoulos; Monika Brüggemann; Frederic Davi; Kostas Stamatopoulos; Chrysoula Belessi
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

4.  B cell receptor light chain repertoires show signs of selection with differences between groups of healthy individuals and SLE patients.

Authors:  Nathan Schoettler; Dongyao Ni; Martin Weigert
Journal:  Mol Immunol       Date:  2012-04-18       Impact factor: 4.407

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.